We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPLE3:BMFBOVESPACompanhia Paranaense de Energia Analysis

Data as of 2026-03-14 - not real-time

R$14.09

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

CPLE3 is trading at R$14.09, comfortably above the 20‑day SMA of R$14.50 but still below the 200‑day SMA of R$12.44, indicating a short‑term bullish bias within a longer‑term uptrend. The RSI sits at 47.6, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, warning of potential downside pressure. Price is holding above the identified support level of R$13.59 and below the resistance at R$15.16, giving a measured upside of roughly 6 %. Volume has been decreasing, which may dampen the strength of any breakout. Volatility over the past 30 days is elevated at about 30 %, yet the beta of 0.27 underscores a defensive profile relative to the market.
Fundamentally, the stock appears undervalued: the DCF fair value of R$14.26 exceeds the current price, and the trailing P/E of 15.7 is well below the industry average of 23.3. The dividend yield of 8.68 % is attractive, but a payout ratio above 130 % raises sustainability concerns. Debt‑to‑equity is high at nearly 88 %, though cash flow generation remains solid, and ROE sits at 11 %. Overall, the combination of modest upside, strong cash yields, and defensive sector positioning supports a favorable outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price is near support with limited upside to resistance
  • bearish MACD signal suggests caution
  • decreasing volume reduces momentum strength

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates ~6% upside
  • P/E well below industry peers
  • high dividend yield enhances total return

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • stable regulated cash flows from utility operations
  • low beta provides defensive characteristics
  • attractive dividend despite sustainability watch

Key Metrics & Analysis

Financial Health

Revenue Growth-0.20%
Profit Margin10.29%
P/E Ratio15.7
ROE10.96%
ROA5.10%
Debt/Equity87.94
P/B Ratio1.8
Op. Cash FlowR$3.0B
Free Cash FlowR$4.4B
Industry P/E23.3

Technical Analysis

TrendBullish
RSI47.6
SupportR$13.59
ResistanceR$15.16
MA 20R$14.50
MA 50R$13.60
MA 200R$12.44
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueR$14.26
Target PriceR$15.02
Upside/Downside6.57%
GradeUndervalued
TypeValue
Dividend Yield8.68%

Risk Assessment

Beta0.27
Volatility30.35%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.